FIELD: medicine.
SUBSTANCE: invention refers to veterinary science and aims at preventing and treating the porcine respiratory disease complex PRDC. What is declared is using a recombinant protein ORF2 PCV2 or an immunogenic composition containing the recombinant protein ORF2 PCV2, for preparing a therapeutic agent for preventing and treating the porcine respiratory disease complex (PRDC) caused by Mycoplasma hyorhinis and/or a PRDC-associated clinical symptom of a notable increase of a death rate in the middle to late feeding phase caused by PCV2, and at least one another pathogen causing PRDC in animals, wherein one pathogen causing PRDC is specified in a group containing PRRSV, Mycoplasma hyopneumoniae, Bordetella bronchiseptica, swine influenza virus, Actinobacillus pleuropneumoniae, Mycoplasma hyorhinis. Streptococcus suis and/or Pasteurella multocida.
EFFECT: invention is high-effective for treating and preventing the porcine respiratory disease complex PRDC.
2 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RELIEVING CONCURRENT INFECTIONS IN PIGS USING PCV2 ANTIGEN | 2008 |
|
RU2491092C2 |
| PREVENTING AND TREATING SUBCLINICAL FORM OF PORCINE CIRCOVIRUS DISEASES (PCVD) | 2008 |
|
RU2520759C2 |
| TREATMENT OF PIGS WITH PCV2 ANTIGEN | 2007 |
|
RU2520087C2 |
| PORCINE CIRCOVIRUS TYPE 3 (PCV3) VACCINES, PRODUCTION AND USE THEREOF | 2020 |
|
RU2813989C2 |
| VACCINES CONTAINING PORCINE PATHOGENS FOR ASSOCIATED UNMIXED USE | 2018 |
|
RU2756767C2 |
| COMBINED PORCINE VACCINE | 2017 |
|
RU2761453C2 |
| VACCINE AGAINST HIGHLY PATHOGENIC PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (HP PRRS) | 2009 |
|
RU2561595C2 |
| COMBINATION VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS (PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS COMBINATION VACCINE) | 2013 |
|
RU2644256C2 |
| INTRADERMAL VACCINE AGAINST PCV2 AND PRRS VIRUS INFECTION | 2017 |
|
RU2746127C2 |
| IMMUNOGENIC COMPOSITIONS FOR IMMUNIZATION OF PIGS AGAINST CIRCOVIRUS TYPE 3 AND METHODS OF PRDUCTION AND APPLICATION THEREOF | 2016 |
|
RU2744193C2 |
